Pulmonary hypertension clinical trials

Explore recruiting pulmonary hypertension clinical trials.

Recruiting pulmonary hypertension studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pulmonary hypertension trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

IMPACT-CTEPH Initial dual oral coMbination therapy versus standard-of-care initial oral monotherapy Prior to balloon pulmonary Angioplasty in patients with inoperable Chronic thromboembolic pulmonary hyperTension”

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Improvement of MRI assessed cerebral Perfusion and oxygenation by luspatercept-induced Anemia Correction in non-transfusion dependent Thalassemia

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

ERASE PH-COPD

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A PHASE 2A, OPEN-LABEL SINGLE ARM MULTICENTER EXPLORATORY STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF ORAL DOSES OF ROC-101 IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) AND PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE (ILD-PH)

Spain, Italy, Poland, France, Latvia, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Prospective, Open-label, Platform Study for Long-term Follow-up of Participants Using Study Intervention in Pulmonary Hypertension Parent Studies

Bulgaria, Poland, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction

France, Italy, Germany, Czechia, Austria, Poland +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pulmonary hypertension trials by city

Pulmonary hypertension in Toronto Pulmonary hypertension in Vancouver Pulmonary hypertension in Montreal Pulmonary hypertension in Calgary Pulmonary hypertension in Edmonton Pulmonary hypertension in Ottawa Pulmonary hypertension in Winnipeg Pulmonary hypertension in Quebec City Pulmonary hypertension in Hamilton Pulmonary hypertension in Kitchener Pulmonary hypertension in London Pulmonary hypertension in Halifax Pulmonary hypertension in New York Pulmonary hypertension in Los Angeles Pulmonary hypertension in Chicago Pulmonary hypertension in Houston

Other conditions

High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Deep vein thrombosis Chronic kidney disease Diabetic kidney disease IgA nephropathy Polycystic kidney disease Migraine Alzheimer's disease Parkinson's disease Multiple sclerosis Epilepsy ALS Huntington's disease